April 13, 2021 — The FDA and CDC on Tuesday really useful that use of the Johnson & Johnson COVID-19 vaccine be paused after reviews of blood clots in sufferers receiving the shot, the FDA and CDC introduced Tuesday.
In an announcement, FDA stated 6.8 million doses of the J&J vaccine have been administered and the company is investigating six reported instances of a uncommon and extreme blood clot occurring in sufferers who acquired the vaccine.
The CDC will convene a gathering of the Advisory Committee on Immunization Practices on Wednesday to assessment the instances.
“This is important to ensure that the health care provider community is aware of the potential for these adverse effects and can plan due to the unique treatment required with this type of blood clot,” the FDA stated on Twitter.
The company plans a ten a.m. news convention to debate the scenario additional. Examine again for extra protection.